Walid Shalata

44PUBLICATIONS

41CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsLiquid biopsiesCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (44)

Sort by Publication Date:

|Jun 25, 2026

Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma.

|May 27, 2026

Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLC.

|May 27, 2026

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.

|May 04, 2026

Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving Immunotherapy.

|Apr 24, 2026

Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites.

|Apr 14, 2026

Investigation of the Prevalence of Associated Genetic Mutations (Co-Mutations) in Patients with Actionable Driver Mutations in Lung Cancer: A Retrospective Study.

Abed Agbarya, Walid Shalata, Edmond Sabo

Pageof 8

Frequent Collaborators

18 joint publications

Abed Agbarya

Keren Rouvinov

Zoé Gabrielle Attal

Mahmoud Abu Amna

Leonard Saiegh

Rashad Naamneh

Wenad Najjar

Muhammad Masalha

Waleed Kian

Fahmi Abu Ghalion

Frequent Collaborators

18 joint publications

Abed Agbarya

7 joint publications

Keren Rouvinov

4 joint publications

Zoé Gabrielle Attal

4 joint publications

Mahmoud Abu Amna